NCT07760779

Brief Summary

The goal of this clinical trial is to examine and compare the effect of behavioral sleep treatment: BBTI (brief behavioral treatment of insomnia) and brief mindfulness (MI), independently and combined vs control on frequency of nighttime awakenings to void (nocturia) and on nighttime urine production in older women over the age 65 years with nocturia. To study the effect of these treatments, participants will be randomly assigned to one of the following groups 1) BBTI alone, 2) MI alone, 3) BBTI+MI, or 4) control: sleep information only without any structured sleep or mindfulness therapy. The study aims to examine the effect of these therapies at end-of-treatment (week 4), as well sustained effects at 3- and 6-months. The main questions the study aims to answer are:

  1. 1.do these treatments reduce the frequency of nighttime awakenings to void
  2. 2.do these treatments reduce the volume of nighttime urine production
  3. 3.do these treatments improve sleep quality

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2026

Expected
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2028

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2029

Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

2.1 years

First QC Date

August 7, 2026

Last Update Submit

August 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Nocturia

    number of nighttime awakenings to void

    4 weeks, 3- and 6-months post-intervention

Other Outcomes (2)

  • Nocturnal polyuria index (NPi)

    4 weeks, 3- and 6-months post-intervention

  • Pittsburgh Sleep Quality Index (PSQI)

    4-weeks, 3- and 6-month post intervention

Study Arms (4)

Control

OTHER
Behavioral: Control

BBTI

EXPERIMENTAL

Brief behavioral treatment of insomnia

Behavioral: Brief behavioral treatment of insomnia

MI

EXPERIMENTAL

Brief mindfulness

Behavioral: MI

BBTI+MI

EXPERIMENTAL

Brief behavioral treatment of insomnia and brief mindfulness

Behavioral: BBTI+MI

Interventions

BBTI: will entail a 45- to 60-minute individual intervention session with instructions regarding sleep education and discussion of homeostatic and circadian mechanisms of human sleep regulation. This education provides the rationale for the 4 main interventions of BBTI: 1. reduce time in bed; 2. get up at the same time every day, regardless of sleep duration; 3. do not go to bed unless sleepy; and 4. do not stay in bed unless asleep

BBTI
MIBEHAVIORAL

Participants in the MI group will be trained to engage in a brief mindfulness method involving body scan with acceptance language training.

MI
ControlBEHAVIORAL

The control condition is intended to emulate the behavioral treatment information generally available to patients.

Control
BBTI+MIBEHAVIORAL

Participants in this arm will receive BBTI as well as MI training.

BBTI+MI

Eligibility Criteria

Age65 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Female
  • Age \> or =65 years
  • Nocturia ≥2/night
  • Poor sleep (Insomnia Severity Index ≥8)
  • MoCA (including trail making) \>26

You may not qualify if:

  • Conditions that affect bladder function: Multiple sclerosis, Alzheimer's disease, spinal cord injury, urethral obstruction, urinary retention, interstitial cystitis, bladder cancer, radiation to the pelvic area, bladder surgery, current or uncontrolled chronic or recurrent bowel issues, bacterial endocarditis
  • cardiac or respiratory disease that limits daily function
  • Unstable or acute medical condition:
  • Untreated, current, severe psychiatric condition (assessed during Visit 1a- medical history)
  • Post void residual ≥ 200ml- assessed during baseline visit
  • Currently diagnosed and/or untreated obstructive sleep apnea, untreated restless leg syndrome, untreated parasomnia
  • Untreated or poorly controlled fluid overload conditions like CHF, diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

NocturiaSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Lower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Shachi Tyagi, MD, MS

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR
  • Shachi Tyagi, MD, MS

    University of Pittsburgh

    STUDY CHAIR
  • Becky D Clarkson, PhD

    University of Pittsburgh

    STUDY DIRECTOR

Central Study Contacts

Shachi Tyagi, MD, MS

CONTACT

Becky D Clarkson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 7, 2026

First Posted

August 12, 2026

Study Start (Estimated)

September 15, 2026

Primary Completion (Estimated)

October 30, 2028

Study Completion (Estimated)

April 30, 2029

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification may be shared with other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Following publication, no end date

Locations